[en] [en] BACKGROUND: New equations to estimate glomerular filtration rate based on creatinine (eGFRcr), cystatin C (eGFRcys) or both (eGFRcr-cys) have been developed by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and the European Kidney Function Consortium (EKFC). There is a need to evaluate the performance of these equations in diverse European settings to inform implementation decisions, especially among people with key comorbid conditions.
METHODS: We performed a cross-sectional study including 6174 adults referred for single-point plasma clearance of iohexol in Stockholm, Sweden, with 9579 concurrent measurements of creatinine and cystatin C. We assessed the performance of the CKD-EPI 2009/2012/2021, EKFC 2021/2023, revised Lund-Malmö (RLM) 2011 and Caucasian, Asian, Pediatric and Adult (CAPA) 2014 equations against measured GFR (mGFR).
RESULTS: Mean age was 56 years, median mGFR was 62 mL/min/1.73 m2 and 40% were female. Comorbid conditions were common: cardiovascular disease (30%), liver disease (28%), diabetes (26%) and cancer (26%). All eGFRcr-cys equations had small bias and P30 (the percentage of estimated values within 30% of mGFR) close to 90%, and performed better than eGFRcr or eGFRcys equations. Among eGFRcr equations, CKD-EPI 2009 and CKD-EPI 2021 showed larger bias and lower P30 than EKFC 2021 and RLM. There were no meaningful differences in performance across eGFRcys equations. Findings were consistent across comorbid conditions, and eGFRcr-cys equations showed good performance in patients with liver disease, cancer and heart failure.
CONCLUSIONS: In conclusion, eGFRcr-cys equations performed best, with minimal variation among equations in this Swedish cohort. The lower performance of CKD-EPI eGFRcr equations compared with EKFC and RLM may reflect differences in population characteristics and mGFR methods. Implementing eGFRcr equations will require a trade-off between accuracy and uniformity across regions.
Disciplines :
Urology & nephrology
Author, co-author :
Fu, Edouard L ; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA ; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden ; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
Levey, Andrew S; Division of Nephrology, Department of Internal Medicine, Tufts Medical Center, Boston, MA, USA
Coresh, Josef; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA
Grams, Morgan E; Division of Precision Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA
Faucon, Anne-Laure ; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden ; INSERM UMR 1018, Department of Clinical Epidemiology, Paris-Saclay University, Paris, France
Elinder, Carl-Gustaf; Division of Renal Medicine, Department of Clinical Intervention, and Technology, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden
Dekker, Friedo W; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
Delanaye, Pierre ; Université de Liège - ULiège > Département de pharmacie > Chimie médicale ; Department of Nephrology-Dialysis-Apheresis, Hôpital Universitaire Carémeau, Nîmes, France
Inker, Lesley A; Division of Nephrology, Department of Internal Medicine, Tufts Medical Center, Boston, MA, USA
Carrero, Juan-Jesus ; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden ; Division of Nephrology, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden
Language :
English
Title :
Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care.
Levey AS, Grams ME, Inker LA. Uses of GFR and albumin-uria level in acute and chronic kidney disease. N Engl J Med 2022;386:2120–8. https://doi.org/10.1056/NEJMra2201153
Levey AS, Coresh J, Tighiouart H et al. Measured and estimated glomerular filtration rate: current status and future directions. Nat Rev Nephrol 2020;16:51–64. https://doi.org/10.1038/ s41581-019-0191-y
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013;3:1–150.
Inker LA, Eneanya ND, Coresh J et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med 2021;385:1737–49. https://doi.org/10.1056/NEJMoa2102953
Pottel H, Bjork J, Courbebaisse M et al. Development and validation of a modified full age spectrum creatinine-based equation to estimate glomerular filtration rate: a cross-sectional analysis of pooled data. Ann Intern Med 2021;174:183–91. https://doi.org/10.7326/M20-4366
Pottel H, Björk J, Rule AD et al. Cystatin C–based equation to estimate GFR without the inclusion of race and sex. N Engl J Med 2023;388:333–43. https://doi.org/10.1056/NEJMoa2203769
Delgado C, Baweja M, Burrows NR et al. Reassessing the inclusion of race in diagnosing kidney diseases: an interim report from the NKF-ASN Task Force. J Am Soc Nephrol 2021;32:1305–17. https://doi.org/10.1681/ASN.2021010039
Lucas A, Wyatt CM, Inker LA. Removing race from GFR estimates: balancing potential benefits and unintended consequences. Kidney Int 2021;100:11–3. https://doi.org/10.1016/j.kint.2021.02.017
Powe NR. Black kidney function matters: use or misuse of race? JAMA 2020;324:737–8. https://doi.org/10.1001/jama.2020.13378
Grubbs V. Precision in GFR reporting: let’s stop playing the race card. Clin J Am Soc Nephrol 2020;15:1201–2. https://doi.org/10.2215/CJN.00690120
Gopalakrishnan C, Patorno E. Time to end the misuse of race in medicine: cases from nephrology. BMJ 2021;375:n2435. https://doi.org/10.1136/bmj.n2435
Gama RM, Kalyesubula R, Fabian J et al. NICE takes ethnicity out of estimating kidney function. BMJ 2021;374:n2159. https://doi.org/10.1136/bmj.n2159
Delgado C, Baweja M, Crews DC et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN Task Force on reassessing the inclusion of race in diagnosing kidney disease. J Am Soc Nephrol 2022;79:268–88.e1.
Gansevoort RT, Anders H-J, Cozzolino M et al. What should European nephrology do with the new CKD-EPI equation? Nephrol Dial Transplant 2022;38:1–6. https://doi.org/10.1093/ndt/gfac254
Delanaye P, Vidal-Petiot E, Bjork J et al. Performance of creatinine-based equations to estimate glomerular filtration rate in White and Black populations in Europe, Brazil and Africa. Nephrol Dial Transplant 2023;38:106–18. https://doi.org/10.1093/ndt/gfac241
Delanaye P, Schaeffner E, Cozzolino M et al. The new, race-free, Chronic Kidney Disease Epidemiology Consortium (CKD-EPI) equation to estimate glomerular filtration rate: is it applicable in Europe? A position statement by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Clin Chem Lab Med 2023;61:44–7. https://doi.org/10.1515/cclm-2022-0928
Delanaye P, Pottel H, Glassock RJ. Americentrism in estimation of glomerular filtration rate equations. Kidney Int 2022;101:856–8. https://doi.org/10.1016/j.kint.2022.02.022
Shlipak MG, Mattes MD, Peralta CA. Update on cystatin C: incorporation into clinical practice. Am J Kidney Dis 2013;62:595–603. https://doi.org/10.1053/j.ajkd.2013.03.027
Carrero JJ, Elinder CG. The Stockholm CREAtinine Measurements (SCREAM) project: fostering improvements in chronic kidney disease care. J Intern Med 2022;291:254–68. https://doi.org/10.1111/joim.13418
Ludvigsson JF, Otterblad-Olausson P, Pettersson BU et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009;24:659–67. https://doi.org/10.1007/s10654-009-9350-y
Wettermark B, Hammar N, Fored CM et al. The new Swedish Prescribed Drug Register—opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007;16:726–35. https://doi.org/10.1002/pds.1294
Ludvigsson JF, Andersson E, Ekbom A et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011;11:450. https://doi.org/10.1186/1471-2458-11-450
Brooke HL, Talback M, Hornblad J et al. The Swedish cause of death register. Eur J Epidemiol 2017;32:765–73. https://doi.org/10.1007/s10654-017-0316-1
Fu EL, Evans M, Carrero JJ et al. Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study. BMJ 2021;375:e066306. https://doi.org/10.1136/bmj-2021-066306
Iohexol Clearance Protocol Stockholm. https://www.karolinska.se/49eb42/globalassets/global/2-funktioner/ funktion-kul/klinisk-kemi/dokument-kopplade-till-pta/ belastningar-anvisningar-och-protokoll/ iohexolclerarance-pt-undersokning-for-externt-bruk.pdf (6 September 2022, date last accessed).
Soveri I, Berg UB, Bjork J et al. Measuring GFR: a systematic review. Am J Kidney Dis 2014;64:411–24. https://doi.org/10.1053/j.ajkd.2014.04.010
Bird NJ, Peters C, Michell AR et al. Comparison of GFR measurements assessed from single versus multiple samples. Am J Kidney Dis 2009;54:278–88. https://doi.org/10.1053/j.ajkd.2009.03.026
Delanaye P, Ebert N, Melsom T et al. Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: how to measure glomerular filtration rate with iohexol? Clin Kidney J 2016;9:682–99. https://doi.org/10.1093/ckj/sfw070
Delanaye P, Flamant M, Dubourg L et al. Single- versus multiple-sample method to measure glomerular filtration rate. Nephrol Dial Transplant 2018;33:1778–85. https://doi.org/10.1093/ndt/gfx345
Grubb A, Blirup-Jensen S, Lindstrom V et al. First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med 2010;48:1619–21. https://doi.org/10.1515/CCLM.2010.318
Karger AB, Long T, Inker LA et al. Improved performance in measurement of serum cystatin C by laboratories participating in the College of American Pathologists 2019 CYS Survey. Arch Pathol Lab Med 2022;146:1218–23. https://doi.org/10.5858/arpa. 2021-0306-CP
Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604–12. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
Bjork J, Grubb A, Sterner G et al. Revised equations for estimating glomerular filtration rate based on the Lund-Malmo Study cohort. Scand J Clin Lab Invest 2011;71:232–9. https://doi.org/10.3109/00365513.2011.557086
Inker LA, Schmid CH, Tighiouart H et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012;367:20–9. https://doi.org/10.1056/NEJMoa1114248
Grubb A, Horio M, Hansson LO et al. Generation of a new cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator. Clin Chem 2014;60:974–86. https://doi.org/10.1373/clinchem.2013.220707
http://www.statistikdatabasen.scb.se/sq/117607.
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1–266.
R CoreTeam. R: a Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2021. https://www.R-project.org/.
Hsu CY, Yang W, Go AS et al. Analysis of estimated and measured glomerular filtration rates and the CKD-EPI equation race coefficient in the chronic renal insufficiency cohort study. JAMA Netw Open 2021;4:e2117080. https://doi.org/10.1001/jamanetworkopen.2021.17080.
Levey AS, Inker LA. GFR as the “gold standard”: estimated, measured, and true. Am J Kidney Dis 2016;67:9–12. https://doi.org/10.1053/j.ajkd.2015.09.014
Delanaye P, Jouret F, Le Goff C et al. Concordance between iothalamate and iohexol plasma clearance. Am J Kidney Dis 2016;68:329–30. https://doi.org/10.1053/j.ajkd.2016.01.007
Seegmiller JC, Burns BE, Schinstock CA et al. Discordance between iothalamate and iohexol urinary clearances. Am J Kidney Dis 2016;67:49–55. https://doi.org/10.1053/j.ajkd.2015.08.020
Levey AS, Titan SM, Powe NR et al. Kidney disease, race, and GFR estimation. Clin J Am Soc Nephrol 2020;15:1203–12. https://doi.org/10.2215/CJN.12791019
Bukabau JB, Yayo E, Gnionsahé A et al. Performance of creatinine- or cystatin C–based equations to estimate glomerular filtration rate in sub-Saharan African populations. Kidney Int 2019;95:1181–9. https://doi.org/10.1016/j.kint.2018.11.045
Moodley N, Hariparshad S, Peer F et al. Evaluation of the CKD-EPI creatinine based glomerular filtration rate estimating equation in Black African and Indian adults in KwaZulu-Natal, South Africa. Clin Biochem 2018;59:43–9. https://doi.org/10.1016/j.clinbiochem.2018.06.014
Fabian J, Kalyesubula R, Mkandawire J et al. Measurement of kidney function in Malawi, South Africa, and Uganda: a multicentre cohort study. Lancet Glob Health 2022;10:e1159–69. https://doi.org/10.1016/S2214-109X(22)00239-X
Delanaye P, Vidal-Petiot E, Björk J et al. Performance of creatinine-based equations to estimate glomerular filtration rate in white and black populations in Europe, Brazil and Africa. Nephrol Dial Transplant 2023;38:106–18. https://doi.org/10.1093/ndt/gfac241
Teo BW, Zhang L, Guh JY et al. Glomerular filtration rates in Asians. Adv Chronic Kidney Dis 2018;25:41–8. https://doi.org/10.1053/j.ackd.2017.10.005
Delanaye P, Cavalier E, Pottel H. Serum creatinine: not so simple! Nephron 2017;136:302–08. https://doi.org/10.1159/000469669
Delanaye P, Cavalier E, Cristol JP et al. Calibration and precision of serum creatinine and plasma cystatin C measurement: impact on the estimation of glomerular filtration rate. J Nephrol 2014;27:467–75. https://doi.org/10.1007/s40620-014-0087-7
Nyman U, Grubb A, Larsson A et al. The revised Lund-Malmo GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population. Clin Chem Lab Med 2014;52:815–24. https://doi.org/10.1515/ cclm-2013-0741
Levey AS, Tighiouart H, Simon AL et al. Comparing newer GFR estimating equations using creatinine and cystatin C to the CKD-EPI equations in adults. Am J Kidney Dis 2017;70:587–89. https://doi.org/10.1053/j.ajkd.2017.04.012
Levey AS, Tighiouart H, Inker LA. Improving glomerular filtration rate estimation-across the age and diversity spectrum. Ann Intern Med 2021;174:265–67. https://doi.org/10.7326/M20-6983
Nyman U, Bjork J, Berg U et al. The modified CKiD study estimated GFR equations for children and young adults under 25 years of age: performance in a European multicenter cohort. Am J Kidney Dis 2022;80:807–10. https://doi.org/10.1053/j.ajkd.2022.02.018
Pottel H, Hoste L, Dubourg L et al. An estimated glomerular filtration rate equation for the full age spectrum. Nephrol Dial Transplant 2016;31:798–806. https://doi.org/10.1093/ndt/gfv454
Pottel H, Vrydags N, Mahieu B et al. Establishing age/sex related serum creatinine reference intervals from hospital laboratory data based on different statistical methods. Clin Chim Acta 2008;396:49–55. https://doi.org/10.1016/j.cca.2008.06.017